Supplementary Table 3. Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults Aged ≥18 Years, Including Control-Patients With Positive or Indeterminant Influenza Test Results — VISION and IVY Networks, September 2023–January 2024

Details

• Alternative Title:
  Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024: Supplementary Table 3. Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults Aged ≥18 Years, Including Control-Patients With Positive or Indeterminant Influenza Test Results — VISION and IVY Networks, September 2023–January 2024
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Subjects:
  COVID-19
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 8
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  1 pdf page
• Volume:
  73
• Issue:
  8
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:8fb05b802633ec3841e9d0eaa08350e95dbb897a5d5281c7223d83166d023e84b008d5ac2bc3814d237b3bd1b5f8d679253318b0c1c70d6658adc5471edfe70a
• Download URL:
  https://stacks.cdc.gov/view/cdc/148436/cdc_148436_DS1.pdf
• File Type:
  [PDF - 146.77 KB ]